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Abstract	
The bis(η5-cyclopentadienyl)titanium(IV) complexes of 5-[(E)-2-(aryl)-1-diazenyl]-2-
hydroxybenzoic acids (H2LXASA) where the aryl group is an X-substituted phenyl ring such that 
X = CH, COEt, CMe, CF, CCl, CBr and N have been synthesised. Two types of titanium(IV) 
compounds viz. (i) [Ti(η5-C5H5)2(O2CC6H3(OH-2)(N=NC6H4(H-4)-5))2] (3) and [Ti(η5-
C5H5)2(O2CC6H3(OH-2)(N=NC6H4(OC2H5-4)-5))2] (4), and (ii) [Ti(η5-C5H5)2(O2CC6H3(O-
2)(N=NC6H4(CH3-4)-5))] (5), [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(F-4)-5))] (6), [Ti(η5-
C5H5)2(O2CC6H3(O-2)(N=NC6H4(Cl-4)-5))] (7), [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(Br-4)-
5))] (8) and [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC5H4(N-4)-5))] (9) were isolated and 
characterised by IR, 1H and 13C NMR spectroscopic techniques. The crystal and molecular 
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structures of 3-9 have been determined by single crystal X-ray crystallography. Compounds 3 
and 4 conform to the formula Cp2Ti(HLXASA-κO)2 with a monodentate carboxylate ligand while 
those of 5-9 conform to Cp2Ti(LXASA-κ2O1,O2) with the dianions chelating the titanium atoms via 
carboxylate-O and hydroxy-O atoms. The common feature of the molecular structures is the 
adoption of distorted tetrahedral geometries based (Cp)2O2 donor sets. Hydroxyl-O‒
H…O(carbonyl) bonding leads to supramolecular chains in the crystal of 4 but, these are absent in 
3. Persistent Cp-C–H…O(carbonyl) interactions, with the carbonyl atoms accepting two or three 
such interactions, lead to supramolecular chains with helical (5, 7 and 8) or linear (6 and 9) 
topologies; C‒X…π interactions also play an important role in the packing of 6-8. 
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1. Introduction 
Organometallic and coordination titanium(IV) compounds are of interest due to their 
reactivity and uses including as reagents for catalytic enantioselective processes [1], organic 
transformations [2], as initiators for polymerization reactions [3], polymerisation catalysts [4-10] 
to metal organic frameworks [11-13] and metallo-supramolecular chemistry [14-19]. Other 
applications include the use of alkoxides or aryloxides precursors for the generation of titanium-
based materials [20-26] and their uses as photo-sensitisers and photo-catalysts [27,28], titanium-
based drugs [29-39] and cell imaging [40-41]. In recent years, substituted titanium-oxo-clusters, 
such as those substituted by acetylacetonate, carboxylates and catecholate derivatives, have 
attracted a great deal of attention, owing to their hydrolytic stability and versatile coordination 
modes [42-46].  
On the other hand, salicylic acid, an ancient anti-inflammatory drug having cancer-
fighting properties, has attracted attention for biological applications and shows a great affinity 
for titanium(IV) ions [47,48]. In spite of the rich chemistry and diverse biological applications of 
titanocene and titanium(IV) based compounds, the synthetic methodologies are not well 
established (vide infra) and the number of isolated and structurally characterised titanocene 
salicylates is scarce. As anticipated, both unsubstituted derivatives, bis(η5-
cyclopentadienyl)titanium(IV) salicylates e.g. [Ti(η5-C5H5)2(O2CC6H4OH)2] (bis(η5-
cyclopentadienyl)bis(salicylato-κO)titanium(IV)) (1) [49], with a monodentate carboxylate 
ligand, and [Ti(η5-C5H5)2(O2CC6H4O)] (bis(η5-cyclopentadienyl)(salicylato-
κ2O1,O2)titanium(IV)) (2) [50], with a chelating dianion, have been described. Compound 1 has 
been synthesised by treating Cp2TiCl2 with sodium salicylate (1:2 molar ratio) in water 
containing acetylacetone wherein the role of the latter reagent is not known [49]. In an another 
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endeavour, compound 2 was prepared from aqueous solutions of Cp2TiCl2, salicylic acid and 
sodium carbonate (1:1.1 molar ratio), the isolation of pure product required meticulous control 
of the experimental conditions as to minimise hydrolytic side reactions. Additionally, shorter 
or prolonged reaction times led to the isolation of either unreacted starting materials or 
oxotitanium(IV) impurities, respectively. In view of the reactions’ complexities, both 1 and 2 
were reinvestigated [51]. Compound 2 was isolated in high yield (86%) from a reaction 
containing equivalent amounts of Cp2TiCl2, triethylamine and sodium salicylate (generated from 
NaOH and salicylic acid) in degassed water under stirring conditions for 10 min. The structure of 
2 was determined from the results of single crystal X-ray crystallography that confirms the 
bidentate chelating nature of the doubly deprotonated salicylate ligand [51]. On the other hand, 
attempted preparations of pure 1 by reacting (i) sodium salicylate and Cp2TiCl2 in two different 
solvents e.g. toluene and water, (ii) salicylic acid and Cp2TiMe2 in toluene and (iii) sodium 
salicylate and acetylacetone treated Cp2TiCl2 in water [49] provided either a mixture of 1 and 2 
or products could not be separated [51], underscoring the synthetic difficulties in this field. 
In spite of such complications, reports on the synthesis of bis(η5-
cyclopentadienyl)titanium(IV) substituted salicylates are available [51,52] but, none of these 
were characterised crystallographically. In an attempt to design molecules that offer the potential 
of hydrogen bonding in their supramolecular structures, i.e. ligands such as 2-mercapto-, 3,5-
dichloro-2-hydroxy- and 3,5-dinitro-2-hydroxybenzoic acids, these were reacted with Cp2TiCl2 
in the presence of aquatic β-cyclodextrin polymer in chloroform, which provided high yield of 
[Ti(η5-C5H5)2(O2CC6H4S)·0.5C6H6], [Ti(η5-C5H5)2(O2CC6H2(3,5-Cl2)O)] and [Ti(η5-
C5H5)2(O2CC6H2(3,5-(NO2)2)O)]; the role of β-cyclodextrin was not fully understood [53]. As a 
consequence of bidentate chelating nature of salicylates in these compounds, a pseudo-
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tetrahedral geometry around titanium(IV) was proposed on the basis of diffraction results. 
Reports on the synthesis of [Ti(η5-(CH3)C5H4)2(O2CC6H4O)] [54], [Ti(η5-
(CH3)C5H4)2{(O2CC6H3-p-O)(NN(C6H4-4-Br))}] [55], [Ti(η5-(CH3)C5H4)2(O2CC6H2(3,5-
(NO2)2)O)] [56] and [Ti(η5-(CH3)C5H4)2(O2CC6H2(5-NO2)2)O)] [57] are also available which 
were synthesised by reacting MeCp2TiCl2, aqueous acetylacetone and substituted salicylic acid 
in chloroform/diethylether mixture but their yields and NMR data are missing. Diffraction data 
on the isolated crystals conform to a distorted tetrahedral/pseudo-tetrahedral geometry around 
titanium(IV), as observed previously. The rarity of bis(η5-cyclopentadienyl)titanium(IV) 
salicylates can be attributed to the high oxophilic character of titanium cations preventing their 
crystallisation under ambient conditions and/or in the presence of any oxygenated source (water 
or adventitious moisture). Moreover, monitoring the kinetics of crystallisation also remains one 
of the most obvious strategies allowing crystalline materials to be obtained. Recently, the 
monodentate mode of salicylates in 1 [49] was confirmed from crystallographic data [58]; 
however, the product was obtained from the reactions of Cp2TiCl2, 5-sulfosalicylic acid and 
salicylic acid in aqueous/chloroform medium wherein the role of 5-sulfosalicylic acid was not 
explained. 
In view of the above technical difficulties and on the basis of previous success with the 
synthesis and structure determination of titanocene carboxylates of the type Cp2Ti(O2CR)2 [59], 
the present work aimed to synthesise a series of bis(η5-cyclopentadienyl)titanium(IV) substituted 
salicylates using a straightforward and reproducible synthetic methodology. For this purpose, 5-
[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids (H2LXASA, Scheme 1) was used where the aryl 
group is an X-substituted phenyl ring. The pro-ligand H2LXASA possesses several interesting 
features: (i) a flexible carboxylate and phenol groups to endow it with strong coordination 
 
 
6 
affinity toward titanium ions; (ii) the presence of hydrogen bond donors such as the hydroxyl 
oxygen and the carboxylate oxygen atoms (and acceptors such as the pyridyl nitrogen) can 
collaborate in self-assemblies, (iii) the diazenyl group linking a bio-compatible salicylate moiety 
and the aryl ring can provide additional flexibility to the ligand molecule and (iv) a pyridine ring 
which provides not only a N-donor atom but also offers rigidity to promote the formation of 
crystalline products. The pro-ligand H2LXASA is a salicylic acid derivative functionalised with a 
aryldiazenyl group and the molecule can function as a mono- (HLXASA)– or dianionic (LXASA)2– 
ligands. In the present contribution, the coordination chemistry of pro-ligand H2LXASA was 
explored systematically towards Cp2TiCl2 which provided two types of titanium(IV) compounds 
viz. (a) bis(η5-cyclopentadienyl)bis(HLXASA-κO)titanium(IV) e.g. [Ti(η5-C5H5)2(O2CC6H3(OH-
2)(N=NC6H4(H-4)-5))2] (3) and [Ti(η5-C5H5)2(O2CC6H3(OH-2)(N=NC6H4(OC2H5-4)-5))2] (4), 
and (b) bis(η5-cyclopentadienyl)(LXASA-κ2O1,O2)titanium(IV)  e.g. [Ti(η5-C5H5)2(O2CC6H3(O-
2)(N=NC6H4(CH3-4)-5))] (5), [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(F-4)-5))] (6), [Ti(η5-
C5H5)2(O2CC6H3(O-2)(N=NC6H4(Cl-4)-5))] (7), [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(Br-4)-
5))] (8) and [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC5H4(N-4)-5))] (9). Compounds 3-9 were 
characterised by IR, 1H and 13C NMR spectroscopic techniques. Further, the crystal and 
molecular structures of each of the compounds has been determined by single crystal X-ray 
crystallography. 
 
 
 
7 
 
Scheme 1. Synthesis of pro-ligand H2LXASA and chemical structures of the Ti(IV) compounds 3-
9 along with the atom-numbering protocol. 
 
2. Experimental 
2.1. Materials and measurements 
Aniline (Sd Fine) and p-phenetidine (Spectrochem) were freshly distilled and p-toludine 
(Merck) was treated with water/ activated charcoal and recrystallised prior to use, while all other 
chemicals were used as purchased without purification: bis(η5-cyclopentadienyl)titanium(IV) 
dichloride,  salicylic acid (Merck), p-fluoroaniline, 4-aminopyridine (Spectrochem), p-
chloroaniline and p-bromoaniline (SRL). The solvents used in the reactions were of AR grade 
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and were dried using standard procedures. Benzene, toluene, hexane and THF were distilled 
from benzophenone/sodium while methanol was distilled over activated magnesium. 
Triethylamine was dried over calcium hydride and distilled. All manipulations were performed 
using standard Schlenk anaerobic lines in an atmosphere of dry dinitrogen or argon, unless 
otherwise stated. Melting points were measured using a Büchi M-560 melting point apparatus 
and are uncorrected. IR spectra in the range 4000-400 cm–1 were obtained on a Perkin Elmer 
Spectrum BX series FT-IR spectrophotometer with samples investigated as KBr discs. 1H and 
13C NMR spectra were recorded on a Bruker AMX 400 spectrometer at 400.13 and 100.62 MHz, 
respectively. 1H and 13C chemical shifts were referenced to Me4Si and CDCl3 set at 0.00 and 
77.0 ppm, respectively. Note: Reactions can be conducted in toluene, however, synthetic 
conveniences, particularly the higher boiling point of toluene, led to the choice of benzene. Care 
in handling benzene should be exercised. 
2.2. Synthesis of pro-ligands and sodium salts 
Pro-ligands H2LXASA viz. 5-[(E)-2-phenyl-1-diazenyl]-2-hydroxybenzoic acid (H2LASA), 
5-[(E)-2-(4-methylphenyl)-1-diazenyl]-2-hydroxybenzoic acid (H2LMASA), 5-[(E)-2-(4-
bromophenyl)-1-diazenyl]-2-hydroxybenzoic acid (H2LBASA) [60], 5-[(E)-2-(4-chlorophenyl)-1-
diazenyl]-2-hydroxybenzoic acid (H2LCASA) [61], 5-[(E)-2-(4-pyridyl)-1-diazenyl]-2-
hydroxybenzoic acid (H2LPASA) [62] were prepared starting from salicylic acid and the 
corresponding aniline using conventional diazonium salt chemistry, in accordance with literature 
procedures. Synthetic and spectral details for the pro-ligands 5-[(E)-2-(4-ethoxyphenyl)-1-
diazenyl]-2-hydroxybenzoic acid (H2LOEASA) and 5-[(E)-2-(4-fluorophenyl)-1-diazenyl]-2-
hydroxybenzoic acid (H2LFASA) are described below. 
2.2.1. Synthesis of 5-[(E)-2-(4-ethoxyphenyl)-1-diazenyl]-2-hydroxybenzoic acid (H2LOEASA) 
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An analogous method to that used for the preparation of H2LASA [60] was followed using 
p-phenetidine (5.00 g, 36.44 mmol) and salicylic acid (5.02 g, 35.85 mmol). The yellow reaction 
mixture was acidiﬁed with dilute acetic acid and the obtained precipitate was washed with water 
and dried. The crude product was washed with hexane to remove any tarry materials and 
recrystallised from methanol to yield orange crystalline material of H2LOEASA. Yield: 6.72 g, 
64%. M. p.: 190-192 ˚C. Anal. found: C, 62.80; H, 4.80; N, 10.03. Calcd for C15H14N2O4: C, 
62.93; H, 4.93; N, 9.79%. IR absorptions (cm-1): 1656 ν(OCO)asym, 1600, 1581, 1478, 1460, 
1250, 1221, 1140, 840, 767, 520, 468. 1H NMR (DMSO-d6/CDCl3) δH: 8.34 [d, 2.1 Hz, 1H, H-
6], 7.95 [dd, 9.0 & 2.1 Hz, 1H, H-4], 7.78 [XX' portion of AA'XX', 2H, H-3' & H-5'], 6.97 [d, 
9.0 Hz, 1H, H-3], 6.91 [AA' portion of AA'XX', 2H, H-2' & H-6'], 4.62 [brs, 1H, OH], 4.04 [q, 
2H, CH2], 1.37 [t, 3H, CH3]. Signal for the carboxylic acid were exchanged due to presence of 
water in the solvent. 13C{1H} NMR (DMSO-d6/CDCl3) δC: 172.54 [COO], 163.72 [C-2], 161.02 
[C-1'], 146.54 [C-5], 145.20 [C-4'], 128.16 [C-4], 126.78 [C-6], 124.35 [C-3' & C-5'], 117.94 [C-
3], 114.54 [C-2' & C-6'], 112.82 [C-1], 63.67 [CH2], 14.64 [CH3]. 
2.2.2. Synthesis of 5-[(E)-2-(4-fluorophenyl)-1-diazenyl]-2-hydroxybenzoic acid (H2LFASA) 
An analogous method to that used for the preparation of H2LCASA [61] was followed 
using p-fluroaniline (5.0 g, 45.02 mmol) and salicylic acid (6.21 g, 45.02 mmol). The yellow 
reaction mixture was acidiﬁed with dilute acetic acid and the obtained precipitate was washed 
with water and dried. The crude product was washed with hexane to remove any tarry materials 
and recrystallised from methanol to yield yellow microcrystalline product of H2LCASA. Yield: 
6.72 g, 57%. M. p.: 235-236 ˚C. Anal. found: C, 59.80; H, 4.10; N, 10.93. Calcd for 
C13H9FN2O3: C, 60.00; H, 3.49; N, 10.77%.  IR absorptions (cm-1): 1665 ν(OCO)asym,1616, 1575, 
1477, 1455, 1395, 1379, 1311, 1217, 1201, 1178, 1078, 1065, 1009, 897, 840, 829, 708, 663, 
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567, 469. 1H NMR (DMSO-d6/CDCl3) δH; 11.65 [brs, 1H, COOH], 8.39 [d, 1H, H-6], 7.97 [dd, 
1H, H-4], 7.81 [XX' portion of AA'XX', 2H, H-3' & H-5'], 7.11 [AA' portion of AA'XX', 2H, H-
2' & H-6'], 7.00 [d, 9.0 Hz, 1H, H-3], 6.14 [brs,1H, OH]. 13C{1H} (DMSO-d6/CDCl3) δH: 172.11 
[COO], 165.17 and 162.67 [C-4', (13C-19F = 251 Hz)], 164.29 [C-2], 148.86 [C-1'], 144.87 [C-5], 
128.20 [C-4], 127.33 [C-6], 124.52 and 124.44 [C-3' & C-5', (13C-19F = 8.0 Hz)], 118.05 [C-3], 
115.99 and 115.76 [C-2' & C-6', (13C-19F = 23 Hz)], 113.02 [C-1]. 
Sodium salts viz. sodium 5-[(E)-2-(phenyl)-1-diazenyl]-2-hydroxybenzoate (NaHLASA) 
[60] and sodium 5-[(E)-2-(4-pyridyl)-1-diazenyl]-2-hydroxybenzoate (NaHLPASA) [62] were 
prepared by the method described earlier. An analogous method to that used for the preparation 
of NaHLASA [60] was followed for the preparation of sodium 5-[(E)-2-(4-ethoxyphenyl))-1-
diazenyl]-2-hydroxybenzoate (NaHLOEASA). Dark-red powder; M. p.: > 350 ˚C. IR absorptions 
(cm-1): 1600 ν(OCO)asym, 1585, 1493, 1484, 1464, 1441, 1367, 1317, 1292, 1257, 1176, 1141, 
1026, 834, 767, 691, 575. 
2.3. Synthesis of titanocene compounds 3-9 
2.3.1. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(OH-2)(N=NC6H4(H-4)-5))2] (3) 
A freshly prepared solution of titanocene dichloride (0.100 g, 0.401 mmol) in anhydrous 
benzene (15 ml) was added to a stirred suspension of NaHLASA (0.230 g, 0.883 mmol) in 
anhydrous benzene (15 ml) and the stirring was continued at 40 ˚C for 4 h. The dark-red reaction 
mixture was evaporated to dryness, washed with hot hexane and dried in vacuo. The residue was 
extracted into hot anhydrous chloroform (20 ml) and filtered through a frit covered with pre-
dried neutral silica (3 cm layer, mesh size 100-200) and eluted further with anhydrous 
chloroform (3 x 1 ml). The clear red filtrate was concentrated using a rotary evaporator to around 
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3 ml, which upon standing overnight afforded orange crystals of 3 at ambient temperature. 
Crystals were washed with a small amount of benzene and dried in vacuo. Yield: 0.15 g, 56 %. 
M. p.: 180-183 ˚C. Anal. found: C, 65.20; H, 4.12; N, 9.03. Calcd for C36H28N4O6Ti: C, 65.46; 
H, 4.27; N, 8.48%. IR absorptions (cm-1): 1633 ν(OCO)asym, 1593, 1570, 1484, 1417, 1384, 1356, 
1295, 1251, 1174, 824,  802, 766, 684, 462. 1H NMR (CDCl3) δH: 12.32 [s, 2H, OH], 8.37 [d, 
2H, H-6], 7.82 [m, 4H, H-2' & H-6'], 7.35-7.43 [m, 4H, H-4 & H-4'], 7.22 [m, 4H, H-3' & H-5'], 
6.98-7.03 [m, 2H, H-3], 6.70 [s, 10H, C5H5]. 13C{1H} NMR (CDCl3) δC: 175.52 [COO], 163.82 
[C-2], 151.84 [C-1'], 145.04 [C-5], 130.18 [C-4'], 129.02 [C-4], 128.47 [C-3' & C-5'], 127.38 [C-
6], 122.59 [C-2' & C-6'], 119.41 [C5H5], 117.87 [C-3], 115.52 [C-1]. 
2.3.2. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(OH-2)(N=NC6H4(OC2H5-4)-5))2] (4) 
Two synthetic procedures are described below. 
Method 1: An analogous method to that used for the preparation of 3 was followed using 
titanocene dichloride (0.100 g, 0.401 mmol) and NaHLOEASA (0.256 g, 0.832 mmol) except that 
the reaction mixture was directly filtered and washed with benzene. Red-orange crystals were 
washed with small amount of hexane and dried in vacuo. Yield: 0.19 g, 64 %. M. p.: 171-173 ˚C. 
Anal. found: C, 64.50; H, 4.18; N, 7.40. Calcd for C40H36N4O8Ti: C, 64.18; H, 4.85; N, 7.48%. 
IR absorptions (cm-1): 1631 ν(OCO)asym, 1604, 1582, 1499, 1477, 1392, 1335, 1247, 1216, 923, 
825, 774, 462, 517. 1H NMR (CDCl3) δH: 12.25 [s, 2H, OH], 8.32 [d, 2H, H-6], 7.80 [XX' 
portion of AA'XX', 4H, H-3' & H-5'], 7.35 [AA' portion of AA'XX', 4H, H-2' & H-6'], 6.90-7.02 
[m, 4H, H-3 & H-4], 6.69 [s, 10H, C5H5], 4.01 [q, 4H, CH2], 1.37 [t, 6H, CH3]. 13C{1H} NMR 
(CDCl3) δC: 175.64 [COO], 163.31 [C-2], 160.78 [C-1'], 146.23 [C-5], 145.19 [C-4'], 128.04 [C-
4], 127.15 [C-6], 124.43 [C-3' & C-5'], 119.41 [C5H5], 119.27 [C-2' & C-6'], 114.65 [C-3], 
114.10 [C-1], 63.67 [CH2], 14.78 [CH3]. 
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Method 2: A freshly prepared solution of titanocene dichloride (0.10 g, 0.40 mmol) in 
anhydrous benzene (15 ml) was added to a stirred solution of H2LOEASA (0.23 g, 0.80 mmol) in 
anhydrous benzene (15 ml). Subsequently to the clear reaction mixture, a benzene solution (10 
ml) of NEt3 (0.080 g, 0.79 mmol) was added drop-wise where upon the wine-red solution turns 
dark-red along with precipitation of Et3N·HCl. The reaction mixture was slowly heated to 40 ˚C 
and stirring was continued for an additional 4 h. The dark-red solution was filtered through a frit 
covered with pre-dried neutral silica (3 cm layer, mesh size 100-200) and eluted with anhydrous 
benzene (3 x 1 ml). The clear filtrate was concentrated using a rotary evaporator to around 3 ml, 
which upon standing overnight afforded red-orange crystals of 4 at ambient temperature. 
Crystals were washed with small amount of anhydrous hexane and dried in vacuo. Yield: 0.17 g, 
53%. M. p.: 171-173 ˚C. Spectroscopic data of the compound closely match with that reported 
for 4 synthesised by method 1. 
2.3.3. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(CH3-4)-5))] (5) 
A freshly prepared solution of titanocene dichloride (0.100 g, 0.401 mmol) in anhydrous 
benzene (20 ml) was added to a clear stirred solution of H2LMASA (0.102 g, 0.401 mmol) in 
anhydrous benzene (50 ml). Subsequently, to a clear reaction mixture, a benzene solution (10 ml) 
of NEt3 (0.080 g, 0.790 mmol) was added drop-wise where upon the wine-red solution turned 
dark-red along with precipitation of Et3N·HCl. The reaction mixture was slowly heated to 40 ˚C 
and stirring was continued for additional 4 h. The dark-red solution was filtered through a frit 
covered with pre-dried neutral silica (3 cm layer, mesh size 100-200) and eluted with anhydrous 
benzene (3 x 1 ml). The clear filtrate was concentrated using a rotary evaporator to around 15 ml, 
which upon standing for a week afforded dark-red crystals of 5 at ambient temperature. Crystals 
were washed with small amount of anhydrous benzene and dried in vacuo. Yield: 0.13 g, 74 %. 
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M. p.: 150-152 ˚C. Anal. found: C, 67.10; H, 4.19; N, 7.80. Calcd for C24H20N2O3Ti: C, 66.68; 
H, 4.66; N, 6.48%. IR absorptions (cm-1): 1614 ν(OCO)asym, 1598, 1472, 1414, 1310, 1248, 1175, 
1128, 1128, 822, 644, 501. 1H NMR (CDCl3) δH: 8.45 [d, 1H, H-6], 8.06 [dd, 1H, H-4], 7.74 
[XX' portion of AA'XX', 2H, H-3' & H-5'], 7.25 [AA' portion of AA'XX', 2H, H-2' & H-6'], 7.05 
[d, 1H, H-3], 6.60 [s, 10H, C5H5], 2.37 [t, 3H, CH3]. 13C{1H} NMR (CDCl3) δC: 173.89 [COO], 
165.49 [C-2], 151.84 [C-1'], 146.51 [C-5], 142.56 [C-4'], 131.12 [C-3' & C-5'], 129.65 [C-4], 
128.49 [C-6], 123.95 [C-2' & C-6'], 121.69 [C5H5], 119.44 [C-3], 114.45 [C-1], 22.84 [CH3]. 
2.3.4. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(F-4)-5))] (6) 
An analogous method to that used for the preparation of 5 was followed using titanocene 
dichloride (0.100 g, 0.401 mmol), H2LFASA (0.113g, 0.401 mmol) and Et3N (0.080 g, 0.790 
mmol). The clear filtrate was concentrated using a rotary evaporator to around 15 ml, which 
upon standing overnight afforded dark-red crystals of 6 at ambient temperature. Crystals were 
washed with small amount of anhydrous benzene and dried in vacuo. Yield: 0.12 g, 68 %. M. p.: 
187-189 ˚C. Anal. found: C, 63.40; H, 3.59; N, 6.10. Calcd for C23H17FN2O3Ti: C, 63.32; H, 
3.93; N, 6.42%. IR absorptions (cm-1): 1622 ν(OCO)asym, 1597, 1497, 1471, 1450, 1417, 1308, 
1247, 1225, 1166, 1129, 1019, 837, 823, 497. 1H NMR (CDCl3) δH: 8.40 [d, 1H, H-6], 7.98 [dd, 
1H, H-4], 7.82 [XX' portion of AA'XX', 2H, H-3' & H-5'], 7.11 [AA' portion of AA'XX', 2H, H-
2' & H-6'], 6.99 [d, 1H, H-3], 6.53 [s, 10H, C5H5]. 13C{1H} NMR (CDCl3) δC: 175.18 [COO], 
167.96 and 165.42 [C-4', (13C-19F = 255 Hz)], 167.04 [C-2], 151.63 [C-1'], 147.61 [C-5], 130.95 
[C-4], 130.10 [C-6], 127.28 and 127.20 [C-3' & C-5', (13C-19F = 8.0 Hz)], 122.94 [C5H5], 
120.81[C-3], 118.76 and 118.53 [C-2' & C-6'], 115.75 [C-1]. 
2.3.5. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(Cl-4)-5))] (7) 
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An analogous method to that used for the preparation of 5 was followed using titanocene 
dichloride (0.100 g, 0.401 mmol), H2LCASA (0.117 g, 0.401 mmol) and Et3N (0.080 g, 0.790 
mmol)). The turbid reaction mixture was filtered; filtrate was concentrated to dryness using a 
rotary evaporator. The brick-red residue was washed with anhydrous hexane and dried in vacuo. 
The solid material was dissolved in anhydrous chloroform (15 ml), filtered through a frit which 
upon standing overnight afforded dark-red crystals of 7 at ambient temperature. Crystals were 
washed with small amount of anhydrous benzene and dried in vacuo. Yield: 0.13 g, 71 %. M. p.: 
148-150 ˚C. Anal. found: C, 60.68; H, 3.70; N, 6.30. Calcd for C23H17ClN2O3Ti: C, 61.02; H, 
3.78; N, 6.19%. IR absorptions (cm-1): 1629 ν(OCO)asym,1598, 1499, 1467, 1499, 1412, 1311, 
1248, 1175, 1125, 1043, 821, 658, 466. 1H NMR (CDCl3) δH: 8.42 [d, 1H, H-6], 8.00 [dd, 1H, H-
4], 7.77 [XX' portion of AA'XX', 2H, H-3' & H-5'], 7.38 [AA' portion of AA'XX', 2H, H-2' & H-
6'], 7.00 [d, 1H, H-3], 6.54 [s, 10H, C5H5]. 13C{1H} NMR (CDCl3) δC: 175.05 [COO], 167.17 
[C-2], 153.39 [C-1'], 147.55 [C-5], 138.90 [C-4'], 131.88 [C-3' & C-5'], 130.94 [C-4], 130.26 [C-
6], 126.50 [C-2' & C-6'], 122.89 [C5H5], 120.80 [C-3], 115.75 [C-1]. 
2.3.6. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC6H4(Br-4)-5))] (8)  
An analogous method to that used for the preparation of 5 was followed using titanocene 
dichloride (0.100 g, 0.401 mmol), H2LBASA (0.117 g, 0.401 mmol) and Et3N (0.080 g, 0.790 
mmol)). The turbid reaction mixture was filtered; filtrate was concentrated to dryness using a 
rotary evaporator. The brick-red residue was washed with anhydrous hexane and dried in vacuo. 
The solid material was dissolved in anhydrous chloroform (30 ml), filtered through a frit, which 
upon standing for three days afforded dark-red crystals of 8 at ambient temperature. Crystals 
were washed with small amount of anhydrous benzene and dried in vacuo. Yield: 0.11 g, 55 %. 
M. p.: 150-152 ˚C. Anal. found: C, 56.10; H, 3.40; N, 5.30. Calcd for C23H17BrN2O3Ti: C, 55.56; 
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H, 3.45; N, 5.63%. IR absorptions (cm-1): 1629 ν(OCO)asym, 1618, 1599, 1449, 1472, 1413, 1393, 
1309, 1261, 1248, 1171, 1127,  1065, 1024, 818, 707, 567, 472. 1H NMR (CDCl3) δH: 8.42 [d, 
1H, H-6], 7.99 [dd, 1H, H-4], 7.69 [XX' portion of AA'XX', 2H, H-3' & H-5'], 7.56 [AA' portion 
of AA'XX', 2H, H-2' & H-6'], 7.00 [d, 1H, H-3], 6.53 [s, 10H, C5H5]. 13C{1H} NMR (CDCl3) δC: 
175.36 [COO], 167.53 [C-2], 154.07 [C-1'], 147.88 [C-5], 135.16 [C-3' & C-5'], 131.26 [C-4'], 
130.64 [C-4], 127.70 [C-6], 127.07 [C-2' & C-6'], 123.21 [C5H5], 121.14 [C-3], 116.07 [C-1]. 
2.3.7. Synthesis of [Ti(η5-C5H5)2(O2CC6H3(O-2)(N=NC5H4(N-4)-5))] (9) 
An analogous method to that used for the preparation of 3 was followed using titanocene 
dichloride (0.100 g, 0.401 mmol) and excess NaHLPASA (0.230 g, 0.883 mmol). The resulting 
dark-red suspension was evaporated to dryness, washed with hot hexane and dried in vacuo. The 
residue was extracted into hot anhydrous dichloromethane (30 ml) and filtered through a frit 
covered with pre-dried neutral silica (3 cm layer, mesh size 100-200) and eluted further with 
anhydrous dichloromethane (3 x 1 ml). The clear red filtrate was concentrated using a rotary 
evaporator to around 20 ml, which upon standing overnight afforded fine dark-red crystals of 9 at 
ambient temperature. Crystals were dissolved by boiling in dichloromethane/DMF (20 ml/1ml, 
v/v) and the clear solution was concentrated to 10 ml, which upon standing at ambient temperature 
for about an hour afforded X-ray quality crystals. Crystals were washed with small amount of 
benzene and dried in vacuo. Yield: 0.13 g, 77 %. M. p.: 328-330 ˚C. Anal. found: C, 63.50; H, 
4.50; N, 10.26. Calcd for C22H17N3O3Ti: C, 63.02; H, 4.09; N, 10.02%. IR absorptions (cm-1): 
1617 ν(OCO)asym, 1590, 1465, 1419, 1309, 1253, 1174, 1122, 825, 790,  603. 1H NMR 
(CDCl3/DMSO-d6) δH: 8.76 [d, 1H, H-6], 8.70 [XX' portion of AA'XX', 2H, H-3' & H-5'], 7.97 
[dd, 1H, H-4], 7.63 [AA' portion of AA'XX', 2H, H-2' & H-6'], 6.74 [d, 1H, H-3], 6.45 [s, 10H, 
C5H5]. 13C{1H} NMR (CDCl3/DMSO-d6) δC: 170.57 [COO], 168.98 [C-2], 156.96 [C-1'], 150.60 
 
 
16 
[C-3' & C-5'], 144.63 [C-5], 130.50 [C-4], 126.03 [C-6], 120.25 [C-3], 120.01 [C-1], 119.18 
[C5H5], 115.77 [C-2' & C-6']. 
2.4. Single crystal X-ray structure determinations of 3-9 
Crystals of compounds 3, 7, 8 (chloroform), 4 and 6 (benzene), 5 (benzene/THF; 2/1 v/v) 
and 9 (dichloromethane/DMF; 20/1 v/v) suitable for single-crystal X-ray diffraction analysis were 
grown from the respective solutions by slow solvent evaporation at room temperature. Intensity 
data for compounds 3-9 were measured at room temperature on an Agilent Xcalibur Eos Gemini 
diffractometer equipped with a CCD area detector and graphite-monochromated Mo Kα radiation 
(λ = 0.71073 Å); Cu Kα radiation (λ = 1.54184 Å) was employed for 5. Data reduction and 
empirical absorption corrections, based on a multi-scan technique, were applied [63]. Each 
structure was solved by direct methods [64] and refined on F2 with anisotropic displacement 
parameters and C-bound H atoms in the riding model approximation [65]. For 3 and 4, the 
hydroxyl-O‒H atoms were located from difference maps but, were refined with the distance 
restraint O‒H = 0.82±0.01 Å. A weighting scheme of the form w = 1/[σ2(Fo2) + (aP)2 + bP] where 
P = (Fo2 + 2Fc2)/3) was introduced for each refinement. The structures were determined at room 
temperature and uniformly featured high displacement parameters, in particular for the 
cyclopentadienyl (Cp) groups. However, the structures were determined unambiguously and are 
entirely consistent with the spectroscopic data. In the refinement of 3, the (-1 0 4), (-1 0 3), (4 1 3) 
and (0 2 6) reflections were omitted from the final cycles of refinement owing to poor agreement. 
In 6, the C17 atom was restrained to be nearly isotropic. The (2 0 4) reflection was omitted from 
the refinement of 7. In 7, the maximum and minimum residual electron density peaks of 1.17 and 
0.45 eÅ-3 were located 1.45 and 0.72 Å from the C5 and Cl1 atoms, respectively. The crystal of 8 
was a two-component twin [twin law: 1 0 0.382   0 -1 0   0 0 -1] with the minor component 
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comprising 0.343(5) of the sample. Crystal data and refinement details are collected in Table 1.  
The molecular structure diagrams were generated by ORTEP for Windows [66] at the 25% 
probability level and the packing diagrams with DIAMOND [67].  Additional data analysis was 
made with PLATON [68]. 
3. Results and discussion 
3.1. Synthesis and spectroscopic characterisation of compounds 3-9 
The paucity of bis(η5-cyclopentadienyl)titanium(IV) salicylates is mainly due to the high 
oxophilic character of Ti-cations, preventing them to crystallise under ambient conditions and/or 
in the presence of any oxygenated source. In view of this, the primary objective herein was set to 
standardise the synthetic procedure and secondly to crystallise the powder/ microcrystalline 
materials to obtain X-ray quality single crystals to enable the determination of their hitherto 
unknown molecular structures. In the current investigation, titanocene arylazosalicylates 3 and 4 
were synthesised by the reactions of titanocene dichloride with two molar equivalents of the 
freshly prepared corresponding sodium salts of the respective pro-ligands in benzene at 40 ˚C 
under stirring. As a representative case, attempted reaction of titanocene dichloride, H2LOEASA and 
NEt3 using 1:2:2 molar ratio in benzene also afforded compound 4. However, the cumbersome 
workup procedure was detrimental to the overall yield and thus synthetic success led to the choice 
of sodium salt method. On the other hand, 5-8 were prepared by the reactions of titanocene 
dichloride with the respective pro-ligands in benzene in the presence of triethylamine in 1:1:2 
molar proportions (Scheme 1). As an exception, by adopting the analogous methodology, 
compound 9 could not be isolated owing to the insolubility of H2LPASA, nevertheless the reaction 
of titanocene dichloride with excess NaHLPASA (1:2 molar proportions) proceeded smoothly in 
benzene (refer to the Experimental section for details). The final yields of the products were >50% 
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which were dependent on the workup conditions applied for the purification and recovery of the 
crystals. Crystalline samples of the compounds 3-9 can be stored for several months in an inert 
environment; of these compounds 3-5 and 9 retain their colour, lustre and melting points. 
However, compounds 4-6 turns into powder with time but retain their original melting points. The 
compounds were characterised by NMR, IR spectroscopy and by single-crystal X-ray 
crystallography. 
The IR spectra of 3-9 show two intense bands in the regions between 1633-1617 and 
1417-1384 cm-1 corresponding to ν(OCO)asym and ν(OCO)sym vibrations, respectively. The 
observed differences between the asymmetric and symmetric vibrations are >200 cm-1; suggesting 
a monodentate coordination of the carboxylate ligand [69]; this assumption was subsequently 
confirmed from the results of single crystal X-ray diffraction studies (see section 3.2). Since the 
titanocene arylazosalicylates in the present investigation were generated from solution methods, it 
was therefore necessary to confirm the purity of the bulk material and also to comprehend the 
solution behaviour of 3-9. For this purpose, solution-state 1H and 13C{1H} NMR studies were 
undertaken using vacuum dried crystalline samples of 3-9 that were dissolved in CDCl3. All the 
samples confirm the purity and displayed the expected signals due to the carboxylate and Cp 
ligands, and the integration values in the spectra are in agreement with those expected for the 
structure types Cp2Ti(HLXASA-κO)2 (3 and 4) and Cp2Ti(LXASA-κ2O1,O2) (5-9) as shown in 
Scheme 1 (refer to Figs S1-S14 for 1H and 13C{1H} NMR spectra). NMR solutions of the 
compounds prepared under dinitrogen/ argon were found to be stable for at least two hours but, 
tended to decompose slowly. Compounds 3 and 4 displayed a singlet at around 12.3 ppm due to 
phenolic OH which is absent in rest of the compounds, corroborating that the ligand bonds to 
titanium(IV) via carboxylate oxygen atom while in 5-9 the di-anionic ligand chelate the titanium 
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atom via carboxylate-O and hydroxy-O atoms. Two chemically equivalent Cp rings were detected 
as sharp singlet in the range 6.53-6.70 ppm in the 1H NMR spectra while a single signal was 
observed between 119.2 and 123.2 ppm in the 13C NMR spectra. The carboxylate carbonyl-carbon 
resonances for the compounds 3-8 were observed at δ 175 ppm and for compound 9 at 170.6 ppm. 
As such, no sign of decomposition was noticed in NMR spectra after dissolution of the crystalline 
samples, confirming that the solid-state structures were retained in solution at least for two hours. 
The subtle changes in the ligand substitution did not affect the general pattern of the NMR spectra 
and the observed signals were generally broad and unresolved which prevented the measurement 
of coupling constants. 
3.2. Description of the crystal and molecular structures of 3-9 
The molecular structures of 3-9 are illustrated in Fig. 1 and selected geometric parameters 
for the seven structures are collated in Table 2. Each crystal is solvent-free and comprises a single 
molecule in the asymmetric unit. The structures fall into two classes, with 3 and 4 having the 
general formula Cp2Ti(HLXASA-κO)2, and those of 5-9 conforming to Cp2Ti(LXASA-κ2O1,O2). The 
difference arises as in the latter series, the hydroxyl group of the carboxylate ligand is also 
deprotonated leading to a dianion so that each complex features a titanium(IV) centre. 
In 3, the titanium atom is coordinated by two oxygen atoms derived from two 
monodentate hydroxylbenzoate ligands. This is confirmed by the observation that the C‒O1, O3 
bond lengths are 0.03-0.04 Å longer than the C=O2, O4 bond lengths and that the carbonyl-O2 
and O4 atoms are approximately 3.5 Å distant from the titanium centre. Intramolecular hydroxyl-
O‒H…O(carbonyl) hydrogen bonds close S(6) loops, Table 3, and confer co-planarity to the 
carboxyl and attached phenyl rings, with the CO2/C6 dihedral angles being 5.1(8) and 3.9(8)° for 
the O1- and O4- carboxylate ligands, respectively. The dihedral angle between the CO2/CO2 
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planes is 23.4(8)°, indicating a non-planar relationship. The coordination geometry is best 
described as pseudo-tetrahedral the two η5-cyclopentadienyl (Cp) anions assumed to occupy a 
single position each. The Ti‒O1, O4 bond lengths are experimentally equivalent. While the Ti–
C(Cp) bond lengths span an experimentally distinct range of 2.332(5) to 2.397(5) Å, no pattern to 
the variations are apparent. Indeed, the Ti…Cg ring centroid distances of 2.049(3) and 2.058(3) Å 
suggest any differences are not chemically significant. The tetrahedral angles range from a narrow 
90.24(12)°, for O1–Ti–O4, to a broad 131.69(12)°, subtended by the more bulky Cp rings. The 
O1-carboxylate ligand is close to co-planar with the dihedral angle between the aromatic residues 
being 2.5(3)° but, the O4-carboxylate ligand is twisted with the equivalent angle being 15.6(2)°. 
The molecular structure of 4 presents very similar features as for 3. The carboxylate residues tend 
to be more co-planar with the CO2/CO2 dihedral angle being 13.2(3)° but, greater twists are noted 
between the CO2/C6 planes, i.e. 6.1(4) and 11.85(14)° for the O1- and O4-carboxylate ligands, 
respectively, even though the intramolecular hydroxyl-O‒H…O(carbonyl) hydrogen bonds persist, 
Table 3. The dihedral angle between the aromatic residues in each ligand is similar, i.e. 10.60(10) 
and 7.23(7)°. 
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Fig. 1.  Molecular structures of 3-9, showing atom labelling schemes and displacement ellipsoids 
at the 25% probability level. 
 
The molecular structures of 5-9 are very similar to each other. In 5, the titanium atom is 
chelated by the carboxylate-O1 and hydroxyl-O3 atoms with the former bond being about 0.05 Å 
longer, an observation correlated with the influence of the proximate electronegative carbonyl-O2 
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atom; the C1‒O1, O2 distances of 1.295(3) and 1.221(3) Å are significantly different in accord 
with expectation. The six-membered chelate ring is not planar and is best described as being based 
on a half-chair with the titanium atom lying 0.592(2) Å above the least-squares plane through the 
O1,O3,C1-C3 atoms [r.m.s. deviation = 0.054 Å]. The coordination geometry is distorted 
tetrahedral within a C2O2 donor set as described above. The O1–Ti–O3 chelate angle is a little 
more acute than the O1–Ti–O4 angles in 3 and 4, and the average Ti–C(Cp) bond lengths tend to 
be a little longer, Table 2. The angle between the carboxylate and phenyl rings is 8.1(3)°, and the 
angle between aromatic residues 15.83(12)°. Essentially the same molecular structures are noted 
for 6-9. The structures of 6 and 7 exhibit the maximum [0.699(2) Å] and minimum [0.567(6) Å] 
deviations of the titanium atom from the chelate ring. The dihedral angle between the CO2/C6 
planes is minimum in 6, i.e. 1.9(4)°, and the maximum twist in the carboxylate ligands is seen in 
9, i.e. 18.01(14)°. 
As discussed in a recent contribution [59], the structural motif observed for 3 and 4 
conforms with expectation for the approximately 25 compounds of the general formula 
Cp2Ti(O2CR)2. By contrast, an evaluation of the crystallographic literature [70] shows there are 
only five precedents for Cp2Ti(salicylate derivatives), which exhibit very similar structural 
features with one notable exception. In the structure of the parent compound, Cp2Ti(salicylate) 
[51], the chelate ring is somewhat more planar than reported for other derivatives and for the 
structures described herein. Thus, the titanium atom lies 0.4180(11) above the remaining five 
atoms of the chelate ring with the maximum deviation from the plane being 0.019(6) Å for the C1 
atom. 
In the crystal of 3, π…π stacking interactions predominate, Table 3. Thus, connections 
between Cp and hydroxylbenzoate rings, and between hydroxylbenzoate and phenyl rings of like 
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molecules connect molecules into a supramolecular layer parallel to (0 1 1), Fig. 2a. Layers stack 
without directional interactions between them as shown in the diagram of the unit cell contents in 
Fig. S15. Quite distinct supramolecular association is evident in the crystal of 4 with hydrogen 
bonding interactions formed between the hydroxyl-O‒H atoms and the carbonyl-O atoms of 
symmetry-related molecules indicating the hydroxyl-O‒H hydrogen atoms are bifurcated owing to 
their participation in intramolecular hydroxyl-O‒H…O(carbonyl) hydrogen bonds. This is 
consistent with the relatively weak nature of the intermolecular hydrogen bonding. As shown in 
Fig. 2b, these interactions lead to a supramolecular chain and four-membered {…HO…}2 synthons. 
Being propagated by 21-screw symmetry along the b-axis direction, the chain has a helical 
topology. The chains are sustained into a three-dimensional architecture by a variety of C‒H…π 
interactions with methylene-, methyl- and Cp-H being donors and hydroxylbenzoate and Cp rings 
being acceptors, Table 3. A view of the unit cell contents is shown in Fig. S16. 
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Fig. 2.  Supramolecular association in the crystals of 3 and 4: (a) 3, a view of the supramolecular 
layer parallel to (0 1 1) sustained by π…π interactions (shown as purple dashed lines) and (b) 4, a 
view of the supramolecular chain sustained by hydroxyl-O‒H…O(carbonyl) hydrogen bonds 
(shown as orange dashed lines); non-participating hydrogen atoms are omitted for reasons of 
clarity. 
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The geometric parameters characterizing the supramolecular association operating in the 
crystals of 5-9 are summarised in Table 4. In the molecular packing of 5, C‒H…O(carbonyl) 
interactions feature prominently with the carbonyl-O2 atom accepting three such interactions 
from two Cp rings to generate a supramolecular chain along the b-axis, Fig. 3a. In essence, two 
Cp rings of one molecule of 5 connect to a carbonyl-O2 of a symmetry-related molecule and a 
second Cp-H atom of the original molecules connects to a second symmetry-related molecule to 
form a chain with a helical topology (21 screw symmetry). The main connections between chains 
are π…π stacking between hydroxybenzoate and Cp rings to form supramolecular layers that 
stack along the a-axis without directional interactions between them, at least based on the 
distance criteria assumed in PLATON [68]; a view of the unit cell contents is shown in Fig. S17.  
In 6, a linear supramolecular chain along the b-axis is again formed through the agency of Cp-C‒
H…O(carbonyl) interactions, again with the carbonyl-O2 atom accepting three contacts, Fig. 3b.  
While the pattern of Cp-C‒H…O(carbonyl) interactions in 6 matches that described for 5, the 
difference is that in 6, the chain is propagated by translational symmetry. As highlighted in Fig. 
S18, the chains are consolidated into the three-dimensional arrangement by π…π interactions 
between centrosymmetrically-related Cp rings and parallel C‒F…π(hydroxybenzoate) 
interactions. Despite having a chlorophenyl group, the crystal of 7 is isostructural with 5 rather 
than with 6. Thus, a helical supramolecular chain is formed along the b-axis, Fig. S19a, and 
supramolecular layers are formed in the bc-plane by π…π stacking interactions between 
hydroxybenzoate and Cp rings. The difference between 5 and 7 arises as directional interactions, 
i.e. of the type parallel C‒Cl…π(hydroxybenzoate), occur between layers to establish the three-
dimensional molecular packing, Fig. S19b. Distinctive packing patterns are found in the crystals 
of 8 and 9. 
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Fig. 3. Views of the supramolecular association sustained Cp-C‒H…O(carbonyl) interactions in 
the crystals of 5, 6, 8 and 9: (a) 5, helical chain, (b) 4, linear chain, (c) 8, layer parallel to (0 1 1) 
and (d) 9, linear chain. The Cp-C‒H…O(carbonyl) interactions are shown as orange dashed lines 
and non-participating hydrogen atoms are omitted for reasons of clarity. 
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In the molecular packing of 8, the carbonyl-O2 atom accepts two C‒H…O(carbonyl) 
interactions with the donors derived from two symmetry-related molecules. As these 
interactions extend laterally, a supramolecular layer ensures, Fig. 3c. These stack along the c-
axis being connected by hydroxybenzoate-C‒H…π(bromophenyl) and parallel C‒
Br…π(hydroxybenzoate) interactions, Table 4 and Fig. S20. The only identifiable 
intermolecular interactions in the crystal of 9 are C‒H…O(carbonyl) interactions whereby the 
carbonyl-O2 atom accepts two contacts derived from two symmetry-related molecules to 
sustain a linear supramolecular chain, Fig. 3d. A view of the unit cell contents is shown in Fig. 
S21. While no formal role for the pyridyl-nitrogen atom is noted, it is proximate to a 
symmetry-related Cp-H atom, being separated by 2.67 Å. 
In summary, the crucial role of C‒H…O(carbonyl) interactions in stabilising 
supramolecular chains in the crystals of 5-9 is established.  The topology of the chain, helical 
(5, 7 and 8) or linear (6 and 9) is dependent on the space group symmetry, Table 1. The 
presence of halide substituents in 6-8 ensures higher dimensionality of the supramolecular 
architectures through their participation in C‒X…π interactions. 
4. Conclusions 
Several new members of bis(η5-cyclopentadienyl)titanium(IV) arylazosalicylates 
were synthesised by conventional synthetic routes in anaerobic conditions in benzene. The 
compounds were characterised by IR and 1H and 13C NMR spectroscopic methods. The bulk 
samples of 3-9 were found to be consistent with their solid-state structures as revealed from 
NMR spectroscopy. The general solid-state constructs of 3-9 appear to be maintained in CDCl3 
solutions at least for couple of hours. X-ray crystallography established the stoichiometry of 3 
and 4 as Cp2Ti(HLXASA-κO)2 and those of 5-9 as Cp2Ti(LXASA-κ2O1,O2) with the molecular 
structures being based on distorted tetrahedral geometries based (Cp)2O2 donor sets and to be 
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largely independent of the nature of the substituents in the terminal phenyl rings. The 
molecular packing in 3 is based on π…π interactions but hydroxyl-O‒H…O(carbonyl) bonding 
leads to supramolecular chains in 4. In 5-9, Cp-C–H…O(carbonyl) interactions persist and lead 
to supramolecular chains with helical (5, 7 and 8) or linear (6 and 9) topologies; C‒X…π 
interactions play an important role in the packing of 6-8. 
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Supplementary materials 
Crystallographic data for compounds 3-9 reported in this paper have been deposited 
with the Cambridge Crystallographic Data Centre (CCDC) as supplementary publication nos. 
CCDC-1850180-CCDC-1850186. These data can be obtained free of charge via 
www.ccdc.cam.ac.uk/getstructures. ESI file contains the (a) Figs. S1-S14. 1H NMR and 13C 
NMR spectra of compounds 3-9, respectively. (b) (i) Fig. S15. A view of the unit cell contents 
of 3 in projection down the a-axis highlighting the stacking of supramolecular layers. The π…π 
interactions are shown as purple dashed lines. (ii) Fig. S16. A view of the unit cell contents of 
4 in projection down the b-axis. The O‒H…O hydrogen bonding and C‒H…π interactions are 
shown as orange and purple dashed lines, respectively. (iii) Fig. S17. A view of the unit cell 
contents of 5 in projection down the b-axis. The C‒H…O and π…π interactions are shown as 
orange and purple dashed lines, respectively. (iv) Fig. S18. A view of the unit cell contents of 
6 in projection down the b-axis. The C‒H…O, π…π and C‒H…F interactions are shown as 
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orange, purple and blue dashed lines, respectively. (v) Fig. S19. (a) a view of the 
supramolecular chain in 7 sustained by C‒H…O(carbonyl) interactions; non-participating 
hydrogen atoms are omitted for reasons of clarity, and (b) a view of the unit cell contents of 7 
in projection down the b-axis. The C‒H…O, π…π and C‒H…Cl interactions are shown as 
orange, purple and blue dashed lines, respectively. (vi) Fig. S20. A view of the unit cell 
contents of 8 in projection down the c-axis. The C‒H…O, π…π and C‒H…Br interactions are 
shown as orange, purple and blue dashed lines, respectively. (vii) Fig. S21.  A view of the unit 
cell contents of 9 in projection down the b-axis. The C‒H…O interactions are shown as orange 
dashed lines. 
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Table 1 
Crystal data and refinement details for compounds 3-9. 
Compound 3 4 5 6 7 
Formula C36H28N4O6Ti C40H36N4O8Ti C24H20N2O3Ti C23H17FN2O3Ti C23H17ClN2O3Ti 
Formula weight 660.52 748.63 432.32 436.28 452.73 
Crystal colour Orange Orange Dark-orange Dark-red Dark-red 
Crystal size/mm3 0.21 x 0.21 x 0.25 0.22 x 0.26 x 0.28 0.08x 0.09 x 0.15 0.09 x 0.09 x 0.25 0.21 x 0.25 x 0.26 
Crystal system Triclinic Monoclinic Monoclinic Triclinic Monoclinic 
Space group P1¯ P21/c P21/c P1¯ P21/c 
a/Å 7.5735(6) 15.3444(6) 7.9077(2) 7.9774(4) 7.8967(7) 
b/Å 14.0769(12) 17.0218(6) 8.8807(2) 8.8773(4) 8.8897(9) 
c/Å 15.0774(13) 14.0822(8) 28.7042(6) 13.7253(7) 28.644(2) 
α/° 76.855(7) 90 90 85.038(4) 90 
 
 
31 
β/° 85.748(7) 98.493(5) 91.637(2) 81.644(4) 91.894(7) 
γ/° 78.948(7) 90 90 87.753(4) 90 
V/Å3 1535.5(2) 3637.8(3) 2014.96(8) 957.72(8) 2009.7(3) 
Z 2 4 4 2 4 
Dc/g cm-3 1.429 1.367 1.425 1.513 1.496 
F(000) 684 1560 896 448 928 
µ/mm-1 0.334 0.295 3.837 0.485 0.587 
Measured data 12263 18513 7278 7227 8875 
θ range/° 3.0 – 28.8 2.9 – 28.8 3.1 – 71.3 3.2 – 28.8 3.1 – 28.8 
Unique data 6978 8273 3843 4282 4550 
Observed data (I ≥ 2.0σ(I)) 4098 5455 3255 3537 2316 
No. parameters 430 486 272 271 271 
R, obs. data; all data 0.076; 0.136 0.055; 0.095 0.042; 0.052 0.047; 0.060 0.081; 0.164 
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a; b in weighting scheme 0.066; 1.344 0.058; 0.633 0.050; 0.193 0.055; 0.523 0.090; 0.511 
Rw, obs. data; all data 0.171; 0.202 0.119; 0.138 0.096; 0.101 0.112; 0.120 0.180; 0.226 
GoF 1.05 1.03 1.05 1.03 1.00 
Range of residual electron 
density peaks/eÅ-3 -0.24 – 0.47 -0.27 – 0.23 -0.24 – 0.31 -0.28 – 0.52 -0.45 – 1.17 
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Table 1 cont. 
Compound 8 9  
Formula C23H17BrN2O3Ti C22H17N3O3Ti 
Formula weight 497.19 419.28 
Crystal colour Dark-orange Maroon 
Crystal size/mm3 0.25 x 0.26 x 0.29 0.19 x 0.19 x 0.21 
Crystal system Monoclinic Triclinic 
Space group P21/c P1¯ 
a/Å 11.464(3) 7.9997(4) 
b/Å 15.566(3) 8.9354(4) 
c/Å 11.788(3) 13.3310(8) 
α/° 90 85.090(4) 
β/° 101.32(2) 78.659(5) 
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γ/° 90 82.736(4) 
V/Å3 2062.6(8) 924.99(9) 
Z 4 2 
Dc/g cm-3 1.601 1.505 
F(000) 1000 432 
µ/mm-1 2.380 0.493 
Measured data 4668 7018 
θ range/° 3.1 – 28.7 3.1 – 28.7 
Unique data 4668 4152 
Observed data (I ≥ 2.0σ(I)) 1935 3513 
No. parameters 272 262 
R, obs. data; all data 0.091; 0.205 0.046; 0.057 
a; b in weighting scheme 0.114; 0 0.058; 0.559 
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Rw, obs. data; all data 0.210; 0.285 0.116; 0.123 
GoF 0.99 1.02 
Range of residual electron 
density peaks/eÅ-3 -0.77 – 0.83 -0.26 – 0.44 
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Table 2 
Geometric parameters (Å, °) for molecular structures 3-9. 
Compound Ti–O1, O(y) Ti–Cg1, Cg2 a O1–Ti–O(y) Cg1–Ti–Cg2 Cp1/Cp2 
dihedral 
CO2/C6 
dihedral 
C6/C6 
dihedral 
3, y = 4 1.947(3), 
1.952(3) 
2.049(3), 
2.058(2) 
90.24(12) 131.69(12) 51.0(3) 5.1(8), 3.9(8) 2.5(3), 15.6(2) 
4, y = 4 1.9637(15), 
1.9572(16) 
2.0590(15), 
2.0576(15) 
88.71(6) 132.37(6) 49.0(2) 6.1(4), 
11.85(14) 
10.60(10), 
7.23(7) 
5, y = 3 1.9681(14), 
1.9223(13) 
2.0712(12), 
2.0611(14) 
87.46(6) 131.91(5) 50.67(16) 8.1(3) 15.83(12) 
6, y = 3 1.9601(15), 
1.9306(16) 
2.0713(17), 
2.0709(14) 
87.05(7) 132.29(7) 50.7(2) 1.9(4) 12.10(15) 
7, y = 3 1.954(4), 
1.918(3) 
2.073(3), 
2.060(3) 
87.84(16) 131.49(14) 50.5(4) 10.0(7) 16.9(3) 
8, y = 3 1.943(5), 2.054(5), 87.1(2) 132.5(2) 49.3(7) 11(2) 6.2(5) 
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1.922(6) 2.061(5) 
9, y = 3 1.9552(15), 
1.9308(17) 
2.0667(16), 
2.0647(18) 
87.13(7) 133.01(7) 51.0(2) 5.5(4) 18.01(14) 
a Cg1 represents the ring centroid of the cyclopentadienyl ring with the lowest C-atom label. 
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Table 3 
Geometric parameters (Å, °) characterising intra- and intermolecular interactions in 3 and 4. 
A H B H…B A…B A–H…B Symmetry operation 
3       
O3 H3o O2 1.78(7) 2.535(6) 153(6) x, y, z 
O6 H6o O5 1.79(6) 2.552(6) 153(5) x, y, z 
Cg(C32-C36) ‒ Cg(C2-C7) ‒ 3.610(3) 2.5(3)a 1-x, 1-y, 1-z 
Cg(C2-C7) ‒ Cg(C8-C13) ‒ 3.853(3) 2.5(2) 1+x, y, z 
Cg(C15-C20) ‒ Cg(C21-C26) ‒ 3.804(3) 15.6(2) 1-x, -y, 2-z 
4       
O3 H3o O2 1.82(3) 2.567(2) 151(2) x, y, z 
O6 H6o O5 1.84(3) 2.567(3) 149(3) x, y, z 
O3 H3o O5 2.43(2) 3.037(2) 131(2) -x, -½+y, 1½-z 
O6 H6o O2 2.53(3) 3.144(3) 133(3) -x, ½+y, 1½-z 
C14 H14a Cg(C2-C7) 2.90 3.783(4) 152 1-x, ½+y, 1½-z 
C29 H29a Cg(C17-C22) 2.67 3.546(3) 151 1-x, -½+y, 1½-z 
C30 H30c Cg(C36-C40) 2.88 3.834(4) 170 1+x, ½-y, ½+z 
C36 H36 Cg(C31-C35) 2.90 3.678(3) 143 x, ½-y, -½+z 
a Angle of inclination between the participating rings. 
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Table 4 
Geometric parameters (Å, °) characterising intermolecular interactions in 5-9. 
A H B H…B A…B A–H…B Symmetry operation 
5       
C18 H18 O2 2.59 3.444(3) 153 1-x, ½+y, 1½-z 
C19 H19 O2 2.46 3.373(3) 169 x, 1+y, z 
C22 H22 O2 2.58 3.372(3) 143 x, 1+y, z 
Cg(C15-C19) ‒ Cg(C8-C13) ‒ 3.9181(15) 10.49(13)a 1-x, 1-y, 1-z 
6       
C18 H18 O2 2.51 3.371(4) 154 x, 1+y, z 
C19 H19 O2 2.45 3.343(3) 161 1-x, 1-y, 1-z 
C20 H20 O2 2.54 3.467(3) 172 x, 1+y, z 
Cg(C14-C18) ‒ Cg(C14-C18) ‒ 3.985(3) 0a -x, 2-y, 1-z 
C11 F1 Cg(C2-C7) 3.549(3) 3.855(3) 92.43(17) -x, -y, -z 
7       
C17 H17 O2 2.59 3.434(7) 151 1-x,1/2+y,3/2-z 
C18 H18 O2 2.45 3.372(8) 170 x, 1+y, z 
C20 H20 O2 2.54 3.353(8) 147 x, 1+y, z 
Cg(C14-C18) ‒ Cg(C8-C13) ‒ 3.936(4) 11.3(3)a 1-x, 1-y, 1-z 
C11 Cl1 Cg(C2-C7) 3.609(3) 3.931(7) 87.2(2) 2-x, -y, 1-z 
8       
 
 
40 
C17 H17 O2 2.50 3.343(14) 152 -x, 1-y, 2-z 
C20 H20 O2 2.54 3.469(13) 175 -x, -½+y, 1½-z 
C4 H4 Cg(C14-C18) 2.91 3.729(10) 147 x, ½-y, -½+z 
C11 Br1 Cg(C2-C7) 3.936(4) 4.000(11) 78.0(3) x, 1½-y, -½+z 
9       
C18 H18 O2 2.53 3.391(4) 154 -x, 1-y, 1-z 
C19 H19 O2 2.49 3.334(4) 151 x, -1+y, z 
a Angle of inclination between the participating rings. 
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